Uterine cancer is the fourth most common cancer in women (behind breast, lung and colon cancers), and is the most common type of gynecologic cancer. Also called endometrial cancer, this condition typically develops after menopause when a woman is between the ages of 50 and 60.
We know a diagnosis of uterine cancer can be overwhelming. That’s why our team spends time with you to be sure you understand your condition and treatment options. Along with other experts from the Sarah Cannon Cancer Institute at Swedish Medical Center, we create a treatment plan that is specifically designed for your needs and health goals.
Treatment often includes surgery from our team as well as radiation, hormone therapy and/or chemotherapy.
Most often, a hysterectomy is recommended for women facing uterine cancer. This procedure is performed to surgically remove the uterus and any cancerous cells contained in it. The hysterectomy is typically coupled with a salpingo-oophorectomy— removal of the fallopian tubes and ovaries.
Our surgeons have been performing these procedures for decades and are highly experienced with the most minimally invasive techniques and technology. Many times, uterine cancer patients are eligible for these procedures to be performed with the aid of the surgical robot. We perform these procedures at the Surgical Robotics Institute at Swedish Medical Center, a specialized unit of the hospital dedicated to caring for patients undergoing robotic procedures.
Robotic surgery provides surgeons with enhanced vision, more dexterity and reduces the impact of surgery on the body. Performed through tiny incisions, these procedures often result in less blood loss and transfusions, less pain, less risk of infection, shorter hospital stays, faster recoveries and a quicker return to normal activity.